Transdermal administration of farnesol-ethosomes enhances the treatment of cutaneous candidiasis induced by Candida albicans in mice
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.04247-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Ting Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China. Hauptthemen laut MEDLINE: Candida albicans, Candidiasis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Liaoning Revitalization Talents Program.
Abstract (Originalsprache)
Cutaneous candidiasis, caused by Candida albicans , is a severe and frustrating condition, and finding effective treatments can be challenging. Therefore, the development of farnesol-loaded nanoparticles is an exciting breakthrough. Ethosomes are a novel transdermal drug delivery carrier that incorporates a certain concentration (10–45%) of alcohols into lipid vesicles, resulting in improved permeability and encapsulation rates compared to conventional liposomes. Farnesol is a quorum-sensing molecule involved in morphogenesis regulation in C. albicans , and these ethosomes offer a promising new approach to treating this common fungal infection. This study develops the formulation of farnesol-loaded ethosomes (farnesol-ethosomes) and assesses applications in treating cutaneous candidiasis induced by C. albicans in vitro and in vivo . Farnesol-ethosomes were successfully developed by ethanol injection method. Therapeutic properties of farnesol-ethosomes, such as particle size, zeta potential, and morphology, were well characterized. According to the results, farnesol-ethosomes demonstrated an increased inhibition effect on cells’ growth and biofilm formation in C. albicans . In Animal infection models, treating farnesol-ethosomes by transdermal administration effectively relieved symptoms caused by cutaneous candidiasis and reduced fungal burdens in quantity. We also observed that ethosomes significantly enhanced drug delivery efficacy in vitro and in vivo . These results indicate that farnesol-ethosomes can provide future promising roles in curing cutaneous candidiasis. IMPORTANCE Cutaneous candidiasis attributed to Candida infection is a prevalent condition that impacts individuals of all age groups. As a type of microbial community, biofilms confer benefits to host infections and mitigate the clinical effects of antifungal treatments. In C. albicans , the yeast-to-hypha transition and biofilm formation are effectively suppressed by farnesol through its modulation of multiple signaling pathway. However, the characteristics of farnesol such as hydrophobicity, volatility, degradability, and instability in various conditions can impose limitations on its effectiveness. Nanotechnology holds the potential to enhance the efficiency and utilization of this molecule. Treatment of farnesol-ethosomes by transdermal administration demonstrated a very remarkable therapeutic effect against C. albicans in infection model of cutaneous candidiasis in mice. Many patients suffering fungal skin infection will benefit from this study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
- College of Life and Health Science, Northeastern University, Shenyang, China.
- Department of pathology, Affiliated Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
- Department of Pathology, Binzhou Medical University, Yantai, Shandong, China.
ORCID-Profile: Chen Ding, Sixiang Sai
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Liaoning Revitalization Talents Program
Zitieren
APA
Shen, T., Tian, B., Liu, W., Yang, X., Sheng, Q., Li, M., Wang, H., Wang, X., Zhou, H., Han, Y., Ding, C., & Sai, S. (2024). Transdermal administration of farnesol-ethosomes enhances the treatment of cutaneous candidiasis induced by Candida albicans in mice. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04247-23
Vancouver
Shen T, Tian B, Liu W, Yang X, Sheng Q, Li M, et al. Transdermal administration of farnesol-ethosomes enhances the treatment of cutaneous candidiasis induced by Candida albicans in mice. Microbiology Spectrum. 2024. doi:10.1128/spectrum.04247-23
BibTeX
@article{Shen2024,
author = {Shen, Ting and Tian, Baocheng and Liu, Wei and Yang, Xuesong and Sheng, Qi and Li, Mengxin and Wang, Haiyan and Wang, Xiuwen and Zhou, Huihui and Han, Yanchun and Ding, Chen and Sai, Sixiang},
title = {Transdermal administration of farnesol-ethosomes enhances the treatment of cutaneous candidiasis induced by Candida albicans in mice},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.04247-23}
}
EUVIMED